Jim Cramer: Healthpeak Properties Is A 'Reasonable' REIT, Recommends Buying This Health Care Stock

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying GRAIL, Inc. (NASDAQ:GRAL), adding that he likes the stock a lot.

Supporting his view, Morgan Stanley analyst Tejas Savant, on March 18, raised the price target on the stock from $16 to $20.

“That' like a dice roll,” Cramer said when asked about Turkcell Iletisim Hizmetleri A.S. (NYSE:TKC). “That's a bridge too far for me.”

On the earnings front, Turkcell, on Feb. 27, posted an FY net profit of 23.52 billion Lira versus a year-ago profit of 18.13 billion Lira.

When asked about Block, Inc. (NYSE:XYZ), he said, “I'm going to say buy half right now, and then if it breaks down below 53, then you can buy more.”

Keefe, Bruyette & Woods analyst Vasundhara Govil, on March 18, upgraded Block from Market Perform to Outperform but lowered the price target from $87 to $80.

Healthpeak Properties, Inc. (NYSE:DOC) is a “reasonable” REIT, Cramer said.

On Feb. 28, Scotiabank analyst Nicholas Yulico maintained Healthpeak Properties with a Sector Outperform and lowered the price target from $24 to $23.

The Mad Money host said Rubrik, Inc. (NYSE:RBRK) is doing “very, very well.”

As per the recent news, NTT DATA partnered with Rubrik on Monday for cybersecurity ransomware protection.

Cramer said Edwards Lifesciences Corporation (NYSE:EW) is a hold and prefers Boston Scientific Corporation (NYSE:BSX) to Edwards Lifesciences.

On the earnings front, Edwards Lifesciences, on Feb. 11, posted better-than-expected quarterly earnings.

“We have to wait another quarter,” Cramer said when asked about Shake Shack Inc. (NYSE:SHAK).

Wells Fargo analyst Anthony Trainor, on Wednesday, initiated coverage on Shake Shack with an Equal-Weight rating and announced a price target of $95.

TransMedics Group, Inc. (NASDAQ:TMDX) is an “interesting” company, Cramer said. “I'm not going to necessarily recommend it right here.”

Needham analyst Mike Matson reiterated TransMedics Group with a Hold rating on Wednesday.

“It's never been this cheap that I can recall,” Cramer said when asked about Arista Networks Inc (NYSE:ANET). “Here's the problem, it's a data center stock.”

On March 5, UBS analyst David Vogt upgraded Arista Networks from Neutral to Buy and raised the price target from $112 to $115.

Price Action:

Turkcell Iletisim Hizmetleri shares fell 2.3% to settle at $6.08 on Thursday.

GRAIL shares gained 0.7% to close at $28.58 during the session.

Arista Networks’ shares fell 3.3% to settle at $78.96.

Shake Shack shares rose 0.3% to settle at $93.62.

TransMedics Group shares gained 0.2% to close at $70.44.

Rubrik shares fell 3.8% to settle at $66.00.

Edwards Lifesciences’ shares rose 0.1% to close at $71.19.

Block shares fell 3.5% to settle at $56.99 on Thursday.

Healthpeak Properties shares fell 0.4% to close at $20.22.

Now Read:

• Netflix, Vertex Pharmaceuticals And More On CNBC’s ‘Final Trades’

Photo: Shutterstock